LifeStance Health Group, Inc. (LFST)
NASDAQ: LFST · Real-Time Price · USD
7.39
-0.07 (-0.94%)
At close: May 22, 2026, 4:00 PM EDT
7.43
+0.04 (0.55%)
After-hours: May 22, 2026, 7:44 PM EDT
LifeStance Health Group Stock Forecast
Stock Price Forecast
According to 10 analysts polled by S&P Global, LifeStance Health Group stock has a consensus rating of "Strong Buy" and an average price target of $10.72. The average 1-year stock price forecast is 45.06% higher than the current stock price, while the lowest is $9.00 (+21.79%) and the highest is $13 (+75.91%).
Price Target: $10.72 (+45.06%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for LifeStance Health Group stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 3 | 3 | 3 | 3 |
| Buy | 3 | 3 | 4 | 4 | 4 | 3 |
| Hold | 0 | 0 | 0 | 0 | 0 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 7 | 7 | 7 | 7 | 7 | 7 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| JP Morgan | JP Morgan | Hold Maintains $8 → $9 | Hold | Maintains | $8 → $9 | +21.79% | May 14, 2026 |
| BTIG | BTIG | Strong Buy Maintains $11 → $12 | Strong Buy | Maintains | $11 → $12 | +62.38% | May 8, 2026 |
| Barclays | Barclays | Buy Maintains $8 → $9 | Buy | Maintains | $8 → $9 | +21.79% | Mar 6, 2026 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $9 → $10 | Strong Buy | Maintains | $9 → $10 | +35.32% | Feb 26, 2026 |
| UBS | UBS | Strong Buy Maintains $10 → $12 | Strong Buy | Maintains | $10 → $12 | +62.38% | Feb 26, 2026 |
Financial Forecast
Revenue This Year
1.70B
from 1.42B
Increased by 19.22%
Revenue Next Year
1.94B
from 1.70B
Increased by 13.96%
EPS This Year
0.13
from 0.02
Increased by 528.98%
EPS Next Year
0.21
from 0.13
Increased by 69.12%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 1.8B | 2.0B | |
| Avg | 1.7B | 1.9B | |
| Low | 1.6B | 1.8B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 24.3% | 20.4% | |
| Avg | 19.2% | 14.0% | |
| Low | 14.1% | 7.8% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 0.19 | 0.27 | |
| Avg | 0.13 | 0.21 | |
| Low | 0.05 | 0.16 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 845.0% | 117.0% | |
| Avg | 529.0% | 69.1% | |
| Low | 145.0% | 24.6% |
Sources: Price targets and consensus ratings provided by S&P Global Market Intelligence. Historical ratings and analyst data provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data sources.